← Open Payments lookup

GENEVA JOHNSON: Open Payments

NPI 1245004506 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$537 in 16 payments from 10 companies in 2025. Trend: 2023 $113 · 2024 $151 · 2025 $537

Food & beverage: $537
CompanyPaymentsAmount
Actelion Pharmaceuticals US, Inc.2$161
Neurocrine BioSciences, Inc.1$118
ABBVIE INC.3$73
VERTEX PHARMACEUTICALS INCORPORATED2$40
PFIZER INC.2$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$31
Amgen Inc.1$27
Bayer Healthcare Pharmaceuticals Inc.1$22
AstraZeneca Pharmaceuticals LP1$18
Lilly USA, LLC1$14

Products named: UPTRAVI, INGREZZA, VRAYLAR, JOURNAVX, OPSUMIT, NURTEC ODT, CAPLYTA, KRYSTEXXA.

Industry payments across NV — which companies pay providers there.